All In Biotech

Drug Trial Radar · NCT03891446

Long-term Safety and Efficacy Extension Trial of Bimatoprost SR

An Extension Trial to Evaluate the Long-term Safety and Efficacy of Bimatoprost SR in Patients With Open Angle Glaucoma or Ocular Hypertension

Last checked: Nov 20, 2026Latest source record: Jul 15, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

455

Actual

Start

Mar 27, 2019

Primary completion

Jun 19, 2026

Study completion Jun 19, 2026

Sponsor

Lead sponsor
AbbVieAbbVie (ABBV)
Sponsor type
Industry
First posted
Mar 27, 2019

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Non randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study will evaluate the long-term safety and efficacy of Bimatoprost Sustained Release (SR) in patients with open-angle glaucoma or ocular hypertension who completed 1 of the 4 Phase 3 Bimatoprost SR studies (192024-091, -092, -093, or -095) and received Bimatoprost SR or who received commercial DURYSTA (Bimatoprost SR) in the open-label Phase 4 ARGOS study (MED-MA-EYE-0648) and completed (or exited early from) the study.

Conditions

  • Open-Angle Glaucoma
  • Ocular Hypertension

Interventions

  • Bimatoprost SRDrug

    Intraocular implant

  • Standard of CareOther

    Standard of care treatment based on investigator's judgement.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Duration of effect of Bimatoprost SRTime frame: Approximately 24 months
  2. Number of patients experiencing a treatment emergent adverse eventTime frame: Approximately 24 months

Locations

124 sites in 26 countries. Site status is shown where the registry gives one.

  • Trinity Research Group /ID# 240190

    Dothan, Alabama

  • Arizona Eye Center - West Ray Road /ID# 240239

    Chandler, Arizona

  • Arizona Glaucoma Specialists /ID# 240212

    Phoenix, Arizona

  • M&M Eye Institute /ID# 240236

    Prescott, Arizona

  • Horizon Eye Specialists & Lasik Centers /ID# 240255

    Sun City, Arizona

  • Angeles Eye Institute /ID# 250397

    Culver City, California

  • Duplicate_Lakeside Vision Center /ID# 240204

    Irvine, California

  • Hamilton Glaucoma Center Shiley Eye Center UCSD /ID# 240196

    La Jolla, California

  • The Eye Research Foundation /ID# 240186

    Newport Beach, California

  • North Bay Eye Associates Inc. /ID# 248912

    Petaluma, California

  • Duplicate_Martel Eye Medical Group /ID# 240291

    Rancho Cordova, California

  • The Clinical Trials Network (CTNx) /ID# 240284

    Redding, California

  • Sacramento Eye Consultants /ID# 240263

    Sacramento, California

  • Pacific Eye Associates /ID# 240234

    San Francisco, California

  • Wolstan & Goldberg Eye Associates /ID# 240221

    Torrance, California

  • Colorado Eye Institute /ID# 248910

    Colorado Springs, Colorado

  • Specialty Retina Center /ID# 240254

    Coral Springs, Florida

  • Nature Coast Clinical Research - Crystal River /ID# 240334

    Crystal River, Florida

  • Bruce Segal, MD /ID# 240292

    Delray Beach, Florida

  • Eye Associates of Fort Meyers /ID# 240218

    Fort Myers, Florida

  • Levenson Eye Associates- Riverside Park Place /ID# 240209

    Jacksonville, Florida

  • MedEye Associates /ID# 240333

    Miami, Florida

  • Logan Ophthalmic Research Inc. /ID# 240280

    Tamarac, Florida

  • International Research Center /ID# 240346

    Tampa, Florida

  • University of South Florida- Neuroscience Institute /ID# 250980

    Tampa, Florida

  • Duplicate_Emory University /ID# 240328

    Atlanta, Georgia

  • Coastal Research Associates /ID# 240192

    Roswell, Georgia

  • Chicago Eye Specialists /ID# 240270

    Bedford Park, Illinois

  • University of Illinois Hospital and Health Sciences System /ID# 250981

    Chicago, Illinois

  • Kovach Eye Institute /ID# 250442

    Elmhurst, Illinois

  • IN Univ School of Medicine /ID# 240294

    Indianapolis, Indiana

  • The Eye Care Institute /ID# 240289

    Louisville, Kentucky

  • Duplicate_Tulane University /ID# 240327

    New Orleans, Louisiana

  • Clinical Eye Research of Boston LLC /ID# 240203

    Winchester, Massachusetts

  • Fraser Eye Center /ID# 240245

    Fraser, Michigan

  • Midwest Vision Research Foundation at Pepose Vision Institute /ID# 250402

    Chesterfield, Missouri

  • Tekwani Vision Center /ID# 240220

    St Louis, Missouri

  • Eye Associates of North Jersey /ID# 250445

    Dover, New Jersey

  • Glaucoma Care Center /ID# 250978

    Livingston, New Jersey

  • Rutgers New Jersey Medical School Campus, Doctors Office Center /ID# 240181

    Newark, New Jersey

Showing 40 of 124 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.